BioPharma Dynamics is expanding its product portfolio for the cell and gene therapy market to offer a range of chemically defined T-cell media, DMSO-free cryopreservation solutions, and recombinant growth factors.
Suitable for cell therapy applications at any stage, the portfolio of cell media products includes immune-cell media, stem-cell media, and cell-cryopreservation solutions. The new ranges support applications which require the expansion or differentiation of mesenchymal stem cells and mesenchymal stromal cells, or expansion or cultivation of T-cells.
With a strong company focus of providing complete solutions to its customers, BioPharma Dynamics already offers a range of products complementary to this media range through cell-culture processing and storage solutions. This includes bottles, sampling systems and specialised cell culture processing bags which are gas permeable and can be custom manufactured in any shape or size to suit the exact application needs.
Whilst in applications where safe freezing of biologics is required, the advanced cryopreservation solutions can be matched with a range of cryopreservation bags and overwraps to preserve cells without compromising functionality. The ability to be able to choose the correct product for a specific step in cell processing is important to end users, providing flexibility whilst ensuring sterility, BioPharma Dynamics has a variety of solutions available that can be further customised to suit each application.
For more information about BioPharma Dynamics new range of products, please visit www.biopharmadynamics.co.uk.